Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01391143
Title Safety Study of MGA271 in Refractory Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors MacroGenics
Indications

lung non-small cell carcinoma

melanoma

renal cell carcinoma

triple-receptor negative breast cancer

prostate carcinoma

head and neck cancer

bladder carcinoma

Therapies

MGA271

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
UCLA Hematology-Oncology Clinic Los Angeles California 90095 United States Details
Yale Cancer Center New Haven Connecticut 06520 United States Details
Moffitt Cancer Center Tampa Florida 33612 United States Details
The University of Chicago Chicago Illinois 60637 United States Details
Norton Cancer Institute Louisville Kentucky 40202 United States Details
University of Maryland Baltimore Maryland 21201 United States Details
Neely Center for Clinical Cancer Research, Tufts Medical Center Boston Massachusetts 02111 United States Details
Massachusetts General Hospital Cancer Center Boston Massachusetts 02114 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
Carolina Biooncology Institute Huntersville North Carolina 28078 United States Details
Hospital of the University of Pennsylvania/Abramson Cancer Center Philadelphia Pennsylvania 19104 United States Details
Sarah Cannon Research Institute Nashville Tennessee 37203 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field